News - Opening the way to the Future of Peptide and Oligonucleotide Pharmaceuticals through the Technology Development Leveraging Innovative Japanese Technologies

News

2023/08/18 PeptiStar will give an invited lecture about the peptide API manufacturing at “SCEJ 54th Autumn Meeting” on September 13, 2023.
2023/08/01 Thank you for your visiting our exhibition booth in the 8th annual
meeting of Nucleic Acids Therapeutics Society of Japan
2023/07/14 An article on our oligonucleotide business will be published in
PHARM TECH JAPAN magazine.
2023/06/30 We will exhibit with Kobelco Eco-Solutions Co., Ltd. at ” The 8th Annual
Meeting of the Nucleic Acids Therapeutics Society of Japan” to be held
from July 11 to 15.
2023/06/16 Our president will give a lecture at “INTERPHEX JAPAN” to be held
from July 5 to 7.
2023/06/05 2023/06/05 Launched “LabSolutions Insight Biologics” , an
oligonucleotide sequence analysis software jointly developed
with Shimadzu Corporation.
2022/11/29 Participated in Boulder Peptide Symposium held in Colorado, USA on Nov. 7-10, 2022
2022/11/12 Our Director will give a lecture at the Japanese Society for Process Chemistry 2022 Winter Symposium to be held on December 2.
2022/10/28 Announcement of Website Renewal
2022/09/08 CAGE Bio, TAGCyx and PeptiStar announce execution of a license and supply agreement for development and commercialization of TAGX-0003 for the treatment of immunodermatology diseases mediated by the IFN-γ pathway
2020/12/01 PeptiStar has issued New Shares through Third-Party Allotment and raised 1.79 billion Yen.
2020/08/31 PeptiStar Inc., Manufacturing Facilities
2020/08/27 We will exhibit & make a presentation at US TIDES (virtual event)
2020/04/22 NeuroScientific Biopharmaceuticals(NSB) announced NSB signed on manufacturing service agreement.
2019/12/06 AMED and PeptiStar announced they accomplished the CiCLE project goal, “establishment of a global leading contract manufacturing organization (CMO) for constrained peptide medicines”.